Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2024-10-16
Summary
Colorectal cancer is one of the malignant tumours with high morbidity and mortality worldwide, posing a serious threat to human health. In recent years, the incidence of colorectal cancer has been on the rise with changes in lifestyle and dietary habits. Although some progress has been made in treatments such as surgery, chemotherapy and radiotherapy, however, the early diagnosis, prognosis assessment and personalised treatment of colorectal cancer still face great challenges. Therefore, it is of great academic value and practical significance to deeply explore the influencing factors of colorectal cancer occurrence, development and its prognosis, especially the research on environmental factors and metabolomics.
Conditions
- Colorectal Cancer
- Metabolic Disease
Interventions
- DIAGNOSTIC_TEST
-
Patients diagnosed with colorectal cancer by pathological biopsy.
- DIAGNOSTIC_TEST
-
colorectal neoplasm
Patients diagnosed with colorectal adenoma confirmed by colonoscopy.
Sponsors & Collaborators
-
Dong Peng
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-10-01
- Primary Completion
- 2025-10-01
- Completion
- 2027-10-01
Countries
- China
Study Locations
More Related Trials
-
A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients
NCT04716257 ·Status: RECRUITING
-
The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer
NCT05420415 ·Status: COMPLETED
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
ctDNA as a Assisted Diagnosis, Early Intervention and Prognostic Marker for Peritoneal Metastases From Colorectal Cancer
NCT04752930 ·Status: UNKNOWN ·Phase: NA
-
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420 ·Status: RECRUITING
-
The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer
NCT05015296 ·Status: UNKNOWN
-
Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial
NCT05755685 ·Status: UNKNOWN ·Phase: PHASE2
-
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
NCT04755907 ·Status: UNKNOWN
-
MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer
NCT03400657 ·Status: UNKNOWN
-
Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer
NCT06040021 ·Status: COMPLETED
-
Colorectal Cancer Dataset in Xijing Hospital From 2011
NCT06308354 ·Status: RECRUITING
-
Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods
NCT05501353 ·Status: RECRUITING
-
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 ·Status: UNKNOWN
-
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
NCT06449937 ·Status: RECRUITING ·Phase: NA
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)
NCT07283575 ·Status: RECRUITING
-
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
NCT06584318 ·Status: RECRUITING ·Phase: NA
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis
NCT05183425 ·Status: UNKNOWN
-
Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer
NCT03142282 ·Status: UNKNOWN ·Phase: PHASE2
-
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
NCT07154173 ·Status: RECRUITING
-
Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer
NCT00689364 ·Status: UNKNOWN
-
Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases
NCT06124729 ·Status: NOT_YET_RECRUITING
-
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
NCT04243057 ·Status: UNKNOWN
-
Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Colorectal Cancer Patients
NCT06614699 ·Status: ACTIVE_NOT_RECRUITING